Literature DB >> 27422250

Reoperative thyroid surgery: can endoscopic areola approach be used?

Bingsheng Guan1, Jinyi Li1, Wah Yang1, Jingge Yang1, Guo Cao1, Peng Sun1, Cunchuan Wang2.   

Abstract

BACKGROUND: Reoperative thyroid surgery is associated with a higher morbidity and has traditionally been done in conventional open approach. This study aimed to evaluate the safety and effectiveness of endoscopic areola approach for reoperative thyroid surgery.
METHODS: A retrospective study was conducted in 46 patients undergoing reoperative thyroid surgery with endoscopic areola approach (endoscopic group) and 70 patients with conventional open approach (open group). Perioperative and follow-up outcomes were compared between the two groups.
RESULTS: Baseline characteristics were comparable between the two groups. Except for two cases of the endoscopic group intraoperatively converted to open surgery, all the other surgery was successfully completed. No significant difference was found between two groups concerning operation time, drainage volume, drainage time and postoperative hospital stay (all P > 0.05). Estimated blood loss was more in the open group than the endoscopic group (P = 0.000). Although not statistically significant, the overall complication rate was less in the endoscopic group than in the open group (21.7 vs. 37.1 %, P = 0.079). Of these complications, transient hypocalcemia was the most common (endoscopic group, 17.4 %; open group, 21.4 %; P = 0.594). One patient of the endoscopic group and 7 patients of the open group suffered from transient recurrent laryngeal nerve (RLN) paralysis (P = 0.210). Moreover, 2 patients of open group experienced permanent RLN paralysis. During the follow-up period (range 1-6 years), no recurrent case was encountered, but the endoscopic group had a higher cosmetic score (9.0 ± 0.9 vs. 5.9 ± 0.9, P = 0.000).
CONCLUSION: In high-volume centers, with strict operation indication, sufficient preoperative evaluation and careful surgical maneuvers, endoscopic areola approach is a safe and effective method for reoperative thyroid surgery, allowing to provide a better cosmetic result and reduce intraoperative blood loss compared with open approach.

Entities:  

Keywords:  Areola approach; Conventional open approach; Endoscopic thyroidectomy; Reoperative thyroid surgery

Mesh:

Year:  2016        PMID: 27422250     DOI: 10.1007/s00464-016-5110-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

1.  Comparison of conventional thyroidectomy and endoscopic thyroidectomy via axillo-bilateral breast approach in papillary thyroid carcinoma patients.

Authors:  Seon Kwang Kim; Sang Yull Kang; Hyun Jo Youn; Sung Hoo Jung
Journal:  Surg Endosc       Date:  2015-10-28       Impact factor: 4.584

2.  Minimally invasive reoperative thyroid surgery.

Authors:  David J Terris; Jonathan Opraseuth
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

3.  Complete Endoscopic Thyroidectomy via Oral Vestibular Approach Versus Areola Approach for Treatment of Thyroid Diseases.

Authors:  Jingge Yang; Cunchuan Wang; Jinyi Li; Wah Yang; Guo Cao; Hong-Meng Wong; Hening Zhai; Weijun Liu
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2015-06       Impact factor: 1.878

4.  "Scarless" (in the neck) endoscopic thyroidectomy (SET) with ipsilateral levels II, III, and IV dissection via breast approach for papillary thyroid carcinoma: a preliminary report.

Authors:  Haichao Yan; Yong Wang; Ping Wang; Qiuping Xie; Qunzi Zhao
Journal:  Surg Endosc       Date:  2014-11-27       Impact factor: 4.584

5.  Endoscopic thyroidectomy via areola approach: summary of 1,250 cases in a single institution.

Authors:  Cunchuan Wang; Zhiqi Feng; Jinyi Li; Wah Yang; Hening Zhai; Nim Choi; Jingge Yang; Youzhu Hu; Yunlong Pan; Guo Cao
Journal:  Surg Endosc       Date:  2014-07-02       Impact factor: 4.584

6.  Morbidity of central neck dissection: primary surgery vs reoperation. Results of a case-control study.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Luca Sessa; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

7.  Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation.

Authors:  Ralph P Tufano; Justin Bishop; Gaosong Wu
Journal:  Laryngoscope       Date:  2012-05-01       Impact factor: 3.325

8.  Long-term follow-up of contralateral lobe in patients hemithyroidectomized for solitary follicular adenoma.

Authors:  H Niepomniszcze; A Garcia; E Faure; A Castellanos; M del Carmen Zalazar; G Bur; B Elsner
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

9.  Reoperative surgery for thyroid disease.

Authors:  Jérémie H Lefevre; Christophe Tresallet; Laurence Leenhardt; Christelle Jublanc; Jean-Paul Chigot; Fabrice Menegaux
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

10.  Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States.

Authors:  Scott M Wilhelm; Christopher R McHenry
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more
  2 in total

1.  Treatment of differentiated thyroid cancer: can endoscopic thyroidectomy via a chest-breast approach achieve similar therapeutic effects as open surgery?

Authors:  Rui Qu; Jinyi Li; Jingge Yang; Peng Sun; Jian Gong; Cunchuan Wang
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

2.  Technique for endoscopic thyroidectomy with selective lateral neck dissection via a chest-breast approach.

Authors:  Youming Guo; Rui Qu; Jinlong Huo; Cunchuan Wang; Xiaochi Hu; Chen Chen; Daosheng Liu; Weiwei Chen; Jing Xiong
Journal:  Surg Endosc       Date:  2018-12-19       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.